Topline Shares of Eli Lilly plummeted 14% on Thursday, pacing what would be the stock’s largest loss in decades after the pharmaceutical giant unveiled data for its obesity treatment pill that fell behind Wall Street’s expectations. Shares of rival Novo Nordisk rose as both companies develop weight loss pills. NurPhoto via Getty Images Key Facts Eli Lilly’s shares dropped more …
Read More »Here’s Why Eli Lilly Shares Are Plummeting
